Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Growth

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 17.583.14-40.091,061.31222.71

What is the latest EBIT Growth ratio of VENUS REMEDIES ?

The latest EBIT Growth ratio of VENUS REMEDIES is 17.58 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202417.58
Mar20233.14
Mar2022-40.09
Mar20211,061.31
Mar2020222.71

How is EBIT Growth of VENUS REMEDIES Trending?

Years EBIT Growth % Change
Mar2024 17.58
459.87
Mar2023 3.14
Positive
Mar2022 -40.09
Negative
Mar2021 1061.31
376.54
Mar2020 222.71 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Growth ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹695.2 Cr 0.9% 23.4% 44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,712.0 Cr -1.3% 1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹176,623.0 Cr -3.2% -0.3% 48% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,285.0 Cr 1.2% 10.7% 19.5% Stock Analytics
CIPLA ₹119,010.0 Cr -0.6% -2.2% -0.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,118.0 Cr -1.5% -5.9% -5.1% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.9%

23.4%

44.3%

SENSEX

0.1%

1%

2.6%


You may also like the below Video Courses